KeerthiGogineniMD

Oncology • Atlanta, GA

Breast Cancer

Associate Professor at Emory School of Medicine

Join to view full profile

Dr. Gogineni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gogineni's full profile

Already have an account?

Office
Emory Winship Cancer Institute
1365C Clifton Road, Suite 4009
Atlanta, GA 30322
Phone+1 404-778-5994

Fax+1 404-778-5530

Education & Training

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Pennsylvania Health SystemResidency, Internal Medicine, 2004 - 2007
University of Maryland School of MedicineClass of 2004

Certifications & Licensure

GA State Medical License 2014 - 2025
PA State Medical License 2004 - 2016
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1) Start of enrollment: 2014 Jan 24
Completed
Phase 1
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy Start of enrollment: 2014 Apr 08
Active, not recruiting
Phase 1
HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Start of enrollment: 2014 Oct 01
Completed
Phase 1
TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery Start of enrollment: 2020 Feb 20
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer Start of enrollment: 2024 Jun 01
Not yet recruiting
Phase 1
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Leveraging Mobile Health to Improve Capecitabine Adherence Among Women With Breast Cancer: A Pilot Randomized Controlled Trial.
Ilana Graetz, Samuel Hernandez, Sara Arshad, Kristina Byers, Jane Meisel
JCO Oncology Practice. 2024-10-01
2 citations
Sunitinib in Patients With Breast Cancer WithorAmplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn
JCO Precision Oncology. 2024-02-01
4 citations
Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia.
Sofia Awan, Geetanjali Saini, Keerthi Gogineni, Justin M Luningham, Lindsay J Collin
Cancer Medicine. 2023-08-01

Press Mentions

Safety and Efficacy of Extended Dosing Intervals of Denosumab in Patients with Solid Cancers and Bone Metastases: A Retrospective StudyDecember 23rd, 2020
Cold Caps to Fight Hair Loss from Chemotherapy: Will the Idea Catch on Here?April 24th, 2017
Survival Rates for Breast Cancer Differ for White, Black Women, Especially in AtlantaOctober 14th, 2016
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member